| M03BX55 |
M03BX55 thiocolchicoside, combinations |
| M03C |
M03C Muscle relaxants, directly acting agents |
| M03CA |
M03CA Dantrolene And Derivatives |
| M03CA01 |
M03CA01 Dantrolene |
| M04 |
M04 Antigout preparations |
| M04A |
M04A Antigout preparations |
| M04AA |
M04AA Preparations inhibiting uric acid production |
| M04AA01 |
M04AA01 Allopurinol |
| M04AA02 |
M04AA02 tisopurine |
| M04AA03 |
M04AA03 febuxostat |
| M04AA51 |
M04AA51 allopurinol, combinations |
| M04AB |
M04AB Preparations increasing uric acid excretion |
| M04AB01 |
M04AB01 probenecid |
| M04AB02 |
M04AB02 sulfinpyrazone |
| M04AB03 |
M04AB03 benzbromarone |
| M04AB04 |
M04AB04 isobromindione |
| M04AB05 |
M04AB05 lesinurad |
| M04AC |
M04AC Preparations with no effect on uric acid metabolism |
| M04AC01 |
M04AC01 colchicine |
| M04AC02 |
M04AC02 cinchophen |
| M04AX |
M04AX Other antigout preparations |
| M04AX01 |
M04AX01 urate oxidase |
| M04AX02 |
M04AX02 pegloticase |
| M05 |
M05 Drugs for treatment of bone diseases |
| M05B |
M05B Drugs affecting bone structure and mineralization |
| M05BA |
M05BA Bisphosphonates |
| M05BA01 |
M05BA01 etidronic acid |
| M05BA02 |
M05BA02 clodronic acid |
| M05BA03 |
M05BA03 Pamidronic acid |
| M05BA04 |
M05BA04 Alendronic acid |